Louisiana-Pacific (NYSE:LPX) announced that its Board of Directors has approved a share repurchase program, which authorizes the company to repurchase $150.00 million in shares on Tuesday, August 7th. This repurchase authorization authorizes the construction company to repurchase up to 3.7% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.
LPX has been the subject of a number of research analyst reports. BMO Capital Markets reiterated a “sell” rating and issued a $27.00 price target on shares of Louisiana-Pacific in a research note on Tuesday, April 24th. ValuEngine lowered shares of Louisiana-Pacific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 1st. DA Davidson upgraded shares of Louisiana-Pacific from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 8th. Zacks Investment Research lowered shares of Louisiana-Pacific from a “strong-buy” rating to a “hold” rating in a research note on Monday, June 4th. Finally, Bank of America upgraded shares of Louisiana-Pacific from a “neutral” rating to a “buy” rating and set a $37.00 price target for the company in a research note on Monday, July 16th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company’s stock. Louisiana-Pacific currently has a consensus rating of “Hold” and an average target price of $33.25.
Hot Undervalued Stocks To Watch Right Now: First Bank(FRBA)
Advisors' Opinion:- [By Joseph Griffin]
First Bank (NASDAQ: FRBA) and Marlin Business Services (NASDAQ:MRLN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.
- [By Shane Hupp]
Media coverage about First Bank (NASDAQ:FRBA) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. First Bank earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave media coverage about the bank an impact score of 43.7118873805192 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Hot Undervalued Stocks To Watch Right Now: Inogen, Inc(INGN)
Advisors' Opinion:- [By Shane Hupp]
Here are some of the news articles that may have impacted Accern Sentiment’s analysis:
Get Inogen alerts: Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ — Wall… (beaumontenterprise.com) EPS Calculations to Consider – Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.
- [By Joseph Griffin]
Inogen Inc (NASDAQ:INGN) Director Raymond Huggenberger sold 10,593 shares of the stock in a transaction that occurred on Monday, July 16th. The shares were sold at an average price of $194.51, for a total value of $2,060,444.43. Following the completion of the sale, the director now directly owns 8,890 shares of the company’s stock, valued at $1,729,193.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
- [By Logan Wallace]
Inogen (NASDAQ:INGN) had its price objective upped by investment analysts at Piper Jaffray Companies to $245.00 in a report issued on Tuesday, The Fly reports. The brokerage currently has an “overweight” rating on the medical technology company’s stock. Piper Jaffray Companies’ target price points to a potential upside of 6.48% from the company’s current price.
- [By Logan Wallace]
Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.
- [By Ethan Ryder]
Inogen Inc (NASDAQ:INGN) Director Heath Lukatch sold 500 shares of the firm’s stock in a transaction that occurred on Friday, October 5th. The shares were sold at an average price of $218.23, for a total value of $109,115.00. Following the sale, the director now owns 1,489 shares of the company’s stock, valued at approximately $324,944.47. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
Hot Undervalued Stocks To Watch Right Now: Calamos Convertible and High Income Fund(CHY)
Advisors' Opinion:- [By Shane Hupp]
Calamos Convertible & Hi Income Fund (NASDAQ:CHY) declared a monthly dividend on Monday, February 4th, Wall Street Journal reports. Stockholders of record on Tuesday, February 12th will be given a dividend of 0.085 per share by the investment management company on Wednesday, February 20th. This represents a $1.02 annualized dividend and a dividend yield of 9.32%. The ex-dividend date of this dividend is Monday, February 11th.
- [By Max Byerly]
Calamos Convertible & Hi Income Fund (NASDAQ:CHY) was the target of a large growth in short interest in September. As of September 14th, there was short interest totalling 705,860 shares, a growth of 35.5% from the August 31st total of 521,121 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily volume of 212,797 shares, the days-to-cover ratio is currently 3.3 days.
Hot Undervalued Stocks To Watch Right Now: CryoPort, Inc.(CYRX)
Advisors' Opinion:- [By Logan Wallace]
Shares of CryoPort Inc (NASDAQ:CYRX) have been assigned an average recommendation of “Buy” from the six ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $19.75.
- [By Motley Fool Transcribers]
CryoPort Inc (NASDAQ:CYRX)Q4 2018 Earnings Conference CallMarch 07, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Logan Wallace]
Get a free copy of the Zacks research report on CryoPort (CYRX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Press coverage about CryoPort (NASDAQ:CYRX) has been trending somewhat positive on Monday, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CryoPort earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave media coverage about the consumer goods maker an impact score of 46.4366918065987 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
- [By Shane Hupp]
CryoPort (NASDAQ:CYRX) had its price objective lifted by Cowen from $11.00 to $16.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. Cowen currently has an outperform rating on the consumer goods maker’s stock.
- [By Ethan Ryder]
CryoPort (NASDAQ:CYRX) posted its quarterly earnings results on Thursday. The consumer goods maker reported ($0.10) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.03), Briefing.com reports. The company had revenue of $4.02 million during the quarter, compared to the consensus estimate of $3.84 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The company’s revenue for the quarter was up 48.3% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.10) earnings per share.
Hot Undervalued Stocks To Watch Right Now: CF Industries Holdings, Inc.(CF)
Advisors' Opinion:- [By Chris Lange]
The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was CF Industries Holdings, Inc. (NYSE: CF) which fell about 3% to $43.04. The stock's 52-week range is $27.27 to $46.20. Volume was about 2.6 million compared to the daily average volume of 2.6 million.
- [By Stephan Byrd]
Californium (CURRENCY:CF) traded up 0.2% against the U.S. dollar during the one day period ending at 17:00 PM Eastern on August 20th. Over the last seven days, Californium has traded flat against the U.S. dollar. One Californium coin can currently be bought for approximately $0.0124 or 0.00000192 BTC on popular exchanges. Californium has a total market capitalization of $30,405.00 and $0.00 worth of Californium was traded on exchanges in the last day.
- [By Shane Hupp]
CF Industries Holdings, Inc. (NYSE:CF) Director Stephen A. Furbacher sold 1,000 shares of CF Industries stock in a transaction that occurred on Wednesday, August 29th. The stock was sold at an average price of $51.43, for a total value of $51,430.00. Following the completion of the transaction, the director now owns 53,690 shares of the company’s stock, valued at approximately $2,761,276.70. The sale was disclosed in a document filed with the SEC, which is available at this link.
- [By Ethan Ryder]
Canaccord Genuity (TSE:CF) had its price target raised by Cormark from C$8.25 to C$9.00 in a report released on Friday.
Shares of Canaccord Genuity opened at C$6.77 on Friday, Marketbeat.com reports. Canaccord Genuity has a 1-year low of C$4.08 and a 1-year high of C$7.49.
- [By Max Byerly]
CF Industries Holdings, Inc. (NYSE:CF) has earned an average recommendation of “Hold” from the twenty-one ratings firms that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $39.09.
No comments:
Post a Comment